Shanchao F. Wu
325 Guohe Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Discovery of Novel Hsp90 Inhibitor-Evodiamine Derivative Conjugates as Potent and Orally Active Antitumor Agents for Colon Cancer Therapy.
Journal: Journal of medicinal chemistry
Published: May 28, 2026
PyfSeTs as a novel and photosensitive reagent for green light-induced arene C-H selenenylation: a versatile strategy for the synthesis of aryl selenides.
Journal: Organic & biomolecular chemistry
Published: March 24, 2026
Evodiamine-Based Nitroreductase Responsive Theranostic Agents for Treatment of Colon Cancer.
Journal: Journal of medicinal chemistry
Published: April 02, 2025
Indolo[3,2-c]isoquinoline Hydroxamic Acid Derivatives as Novel Orally Topoisomerase-Histone Deacetylase Dual Inhibitors for NSCLC Therapy.
Journal: Journal of medicinal chemistry
Published: October 23, 2024
Discovery of Indolo[3,2-c]isoquinoline Derivatives as Novel Top1/2 Dual Inhibitors with Orally Efficacious Antitumor Activity and Low Toxicity.
Journal: Journal of medicinal chemistry
Published: August 06, 2024
Two-Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: April 10, 2024
Transitional urology-current status and prospects of pediatric over-age practice
Journal: Zhonghua yi xue za zhi
Published: April 07, 2024
Discovery of potent natural product higenamine derivatives as novel Anti-Fusobacterium nucleatum agents.
Journal: Bioorganic chemistry
Published: February 25, 2023
Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT).
Journal: Journal of medicinal chemistry
Published: May 19, 2022
Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy.
Journal: Journal of medicinal chemistry
Published: March 03, 2022
Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors.
Journal: Bioorganic chemistry
Published: December 07, 2021
Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.
Journal: European journal of medicinal chemistry
Published: March 03, 2021
Last Updated: 09/26/2026